Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $122.2300 (-1.01%) ($120.9500 - $124.6000) on Thu. May. 11, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.37% (three month average) | RSI | 54 | Latest Price | $122.2300(-1.01%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(44%) XLV(43%) XBI(42%) VT(39%) VYM(39%) | Factors Impacting UTHR price | UTHR will decline at least -1.185% in a week (0% probabilities). VIXM(-15%) TLT(-13%) UUP(-7%) TIP(-1%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.185% (StdDev 2.37%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
5 Day Moving Average | $123.11(-0.71%) | 10 Day Moving Average | $122.99(-0.62%) | 20 Day Moving Average | $122.13(0.08%) | To recent high | -27.4% | To recent low | 1.9% | Market Cap | $5.422b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |